Latest news
Galectin Therapeutics Eliminates $105.8 Million in Debt Through Equity Conversion - citybizcitybiz · Tue, 04 Aug 2026 13:37:08 GMTGalectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:00:00 GMTGalectin chair Uihlein receives 34,376,167 shares in debt-to-equity conversion - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMT